Motley Fool Industry Focus
Energy: Before "Playing" the Oil Glut, Consider This03/26/15
America's abundance of oil has some investors wondering how high levels of storage and shut in wells could impact energy stocks. So Taylor and Tyler break down the situation and give some quick words of caution.
Healthcare: Buy, Sell, or Hold Amarin Corp Plc.
Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock.
Forget Hollywood: How to Invest in the Box Office Itself
Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss the merits and drawbacks of investing in the movie theatre industry.
Financials: Is There Too Much Competition in Banking?
The competitive landscape of the financial industry has changed greatly over the last century – what does this mean for today’s banks?
Tech and Gaming: What Investors Need To Know This Week
Nintendo stock is making moves, while Glu Mobile’sKim Kardashian: Hollywoodgame is climbing the iTunes charts. Motley Fool analysts Nathan Hamilton and Sean O’Reilly discuss why on this week’s industry focus Podcast.
Healthcare: Drug Spending Is Soaring: 3 Can't Miss Take-Away's
A 742% spending surge for hepatitis C, pricey newdiabetes medications, and one new drug class that has payers nervous -- all discussed today by healthcare analyst Michael Douglass and healthcare contributor Todd Campbell on today's Industry Focus.
Consumer Goods: Which American Companies Do The Most Business Abroad?
Motley Fool Analysts Sean O’Reilly and Vincent Shen Dive into the international businesses of some of America’s most storied household brands.
Financials: What do CCAR results mean for the biggest US banks?
Stress tests results reveal whether banks are prepared for economic downturn and if they can return more capital to shareholders.
Technology: This Week In Tech
It was a busy week as normal for tech stocks. Microsoft made a bold move, Intel shares slumped, and Amazon is jumping into the booming IoT industry. Fool analysts Nathan Hamilton and Sean O'Reilly discuss each news event and what it means for...
Energy: Feeling Speculative? Here’s What Not to Do
Today’s Industry Focus is talking Exxon, Chevron, and how not to fall prey to silly journalism in the energy space.
Healthcare: Are These Two Biotech Stocks Too Risky To Buy?
MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks.
Consumer Goods: Are Fast-Casual Restaurant Stocks Entering a Bubble?
Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out.
Financials: Stressing the importance of the Fed’s Stress Tests
Initial bank stress tests results are out, and analysts discuss their importance and potential implications of this Wednesday’s round two results.
Technology: Takeaways from Mobile World Congress
The tech world was focused on one event this past week – The Mobile World Congress. Held in Spain, the event serves as barometer of tech trends in coming years. Fool analysts Nathan Hamilton and Sean O’Reilly sit down to discuss the event and what it...
Healthcare: 2 Tiny Biotechs That Could Have Blockbuster Opportunity
Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss thepitfalls and potential of two small cap biotech stocks.
When “Sin” Pays: Going All-in With the Gaming Industry
Motley Fool analysts Sean O’Reilly and Vincent Shen discuss the global gaming industry and opportunities for investors.
Wisdom from Warren Buffett’s Golden Anniversary Letter
Fool contributor John Maxfield takes on a few key points from this year’s letter to Berkshire Hathaway shareholders.
Technology: The Reality of A.I.
A lot has been said about the concerns and potential capabilities of AI. But how close is AI is to becoming reality? It may be farther out on the horizon than some believe.
Energy: Selling Seadrill For This Reason is the Dumbest Thing You Could...
With Seadrill and Transocean reporting earnings, some analysts out there are saying sell for some pretty ridiculous reasons. Here's why you shouldn't listen to them.
Healthcare: Better Buy: Gilead Sciences, Inc. Vs. Celgene Corporation
In this healthcare edition of Industry Focus, healthcare analyst Michael Douglass and healthcare contributor Todd Campbell speculatewhich of thesetwo biotech titans is a better buy.
- Alexandria, VA
The Motley Fool
2000 Duke St., Fourth Floor
Alexandria, VA 22314703-838-3665